.JPG?ad=18503&adview=true)
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
1 Institute of Molecular and Cellular Biosciences, The University of Tokyo, and 2 Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan
DNA topoisomerase I (TOP1)-DNA covalent complexes are the initial lesions produced by antitumor camptothecins (CPTs). The TOP1-directed drugs stimulate degradation of TOP1 via the ubiquitin-proteasome pathway. We found that proteasome inhibition prevents degradation of DNA-bound TOP1 and sustains high levels of covalent complexes, thus enhancing CPT-induced cell death. Consistent with this, increased degradation of TOP1-DNA covalent complexes was seen in acquired CPT-resistant cells. We found that the resistant cells showed elevated expressions of Cul3, a member of the cullin family of E3 ubiquitin ligases. The reduction in Cul3 expression by small interfering RNA decreased degradation of TOP1-DNA covalent complexes. Conversely, Cul3 overexpression by stable transfection promoted covalent complex degradation and reduced CPT-induced cell death without affecting basal TOP1 expression levels. These results indicate that Cul3, by promoting proteasomal degradation of TOP1-DNA covalent complexes, becomes an important regulator for cellular CPT sensitivity.
This article has been cited by other articles:
|
|
 |
|
  C.-P. Lin, Y. Ban, Y. L. Lyu, S. D. Desai, and L. F. Liu A Ubiquitin-Proteasome Pathway for the Repair of Topoisomerase I-DNA Covalent Complexes J. Biol. Chem., July 25, 2008; 283(30): 21074 - 21083. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. D. Desai, L. M. Wood, Y.-C. Tsai, T.-S. Hsieh, J. R. Marks, G. L. Scott, B. C. Giovanella, and L. F. Liu ISG15 as a novel tumor biomarker for drug sensitivity Mol. Cancer Ther., June 1, 2008; 7(6): 1430 - 1439. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. McEvoy, U. Kossatz, N. Malek, and J. D. Singer Constitutive Turnover of Cyclin E by Cul3 Maintains Quiescence Mol. Cell. Biol., May 15, 2007; 27(10): 3651 - 3666. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kobayashi, M.-I. Kang, Y. Watai, K. I. Tong, T. Shibata, K. Uchida, and M. Yamamoto Oxidative and Electrophilic Stresses Activate Nrf2 through Inhibition of Ubiquitination Activity of Keap1 Mol. Cell. Biol., January 1, 2006; 26(1): 221 - 229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A.J. Vaziri, J. Hill, K. Chikamori, D. R. Grabowski, N. Takigawa, M. Chawla-Sarkar, L. R. Rybicki, A. V. Gudkov, T. Mekhail, R. M. Bukowski, et al. Sensitization of DNA damage-induced apoptosis by the proteasome inhibitor PS-341 is p53 dependent and involves target proteins 14-3-3{sigma} and survivin Mol. Cancer Ther., December 1, 2005; 4(12): 1880 - 1890. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Smith, E. Willmore, C. A. Austin, and N. J. Curtin The Novel Poly(ADP-Ribose) Polymerase Inhibitor, AG14361, Sensitizes Cells to Topoisomerase I Poisons by Increasing the Persistence of DNA Strand Breaks Clin. Cancer Res., December 1, 2005; 11(23): 8449 - 8457. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Hernandez-Munoz, A. H. Lund, P. van der Stoop, E. Boutsma, I. Muijrers, E. Verhoeven, D. A. Nusinow, B. Panning, Y. Marahrens, and M. van Lohuizen From the Cover: Stable X chromosome inactivation involves the PRC1 Polycomb complex and requires histone MACROH2A1 and the CULLIN3/SPOP ubiquitin E3 ligase PNAS, May 24, 2005; 102(21): 7635 - 7640. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
